NASDAQ:OLMA | Free Cash Flow | Olema Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$45.99M
2025-12-31-$38.33M
2025-03-31-$43.98M
2024-12-31-$26.28M$0.00-$26.28M
2024-03-31-$23.5M$153,000.00-$23.65M
2023-12-31-$18.48M
2023-03-31-$20.39M
2022-12-31-$19.71M$173,000.00-$19.88M
2022-03-31-$17.9M$30,000.00-$17.93M
2021-12-31-$18.6M$699,000.00-$19.3M
2021-03-31-$11.08M$420,000.00-$11.5M
2020-12-31-$9.01M$51,000.00-$9.06M
2020-03-31-$2.14M$9,000.00-$2.15M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$146.72M
2024-12-31-$104.35M$159,000.00-$104.51M
2023-12-31-$83.73M
2022-12-31-$82.07M$363,000.00-$82.43M
2021-12-31-$50.69M$1.58M-$52.27M
2020-12-31-$19.87M$56,000.00-$19.92M
2019-12-31-$3.08M